Interphase cytogenetics of prostate cancer: Fluorescence in situ hybridisation (FISH) analysis of Japanese cases

British Journal of Cancer

Volumn 74, Issue 11, 1996, Pages 1699-1704

  Matsuura, H ^a   Shiraishi, T ^a   Yatani, R ^a   Kawamura, J ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Fluorescence in situ hybridization; Interphase cytogenetics; Prostate cancer

Indexed keywords

ARTICLE; CENTROMERE; CHROMOSOME 7; CHROMOSOME 8; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INTERPHASE; JAPAN; MALE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; X CHROMOSOME; Y CHROMOSOME;

EID: 0029832784     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.617     Document Type: Article

References (40)

1. ALERS JC, KRIJTENBURG PJ, VISSERS KJ, BOSMAN FT, VAN DER KWAST TH AND VAN DEKKEN H. (1995). Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chrom. Cancer, 12, 241-250.
2. ALY MS, CIN PD, VAN DE VOORDE W, VAN POPPEL H, AMEYE F, BAERT L AND VAN DEN BERGHE H. (1994). Chromosome abnormalities in benign prostatic hyperplasia. Genes Chrom. Cancer, 9, 227-233.
3. AMIEL A, GABER E, MANOR Y, FEJGIN M, JOSEEPH-LERNER N, RAVID M AND LISHNER M. (1995). Fluorescence in situ hybridization for the detection of trisomies 8 and 9 in polycythemia vera. Cancer Genet. Cytogenet., 79, 153-156.
4. ARPS R, RODEWALD A, SCHMALENBERGER B, CARL P, BRESSEL M AND KASTENDIECK H. (1993). Cytogenetic survey of 32 cancers of the prostate. Cancer Genet. Cytogenet., 66, 93-99.
5. BANDYK MG, ZHAO L, TRONCOSO P, PISTERS LL, PALMER JL, VON ESCHENBAC AC, CHUMG LW AND LIANG JC. (1994). Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chrom. Cancer, 9, 19-27.
6. BELGE G, THOBE B, RIPPE V, BARTNITZEKE S AND BULLERDIEK J. (1994). A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum. Genet., 94, 198-202.
7. BOVA GS, CARTER BS, BUSSEMAKERS MJ, EMI M, FUJIWARA Y, KYPRIANOU N, JACOBS SC, ROBINSON JC, EPSTEIN JI AND WALSH PC. (1993). Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53, 3869-3873.
8. BREITKREUZ T, ROMANAKIS K, LUTZ S, SEITZ G, BONKHOFF H, UNTEREGGER G, ZWERGEL T, ZANG KD AND WULLICH B. (1993). Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res., 53, 4035-4040.
9. BROTHMAN AR, PEEHL DM, PATEL AM AND MCNEAL JE. (1990). Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res., 50, 3795-3803.
10. BROTHMAN AR, WATSON MJ, ZHU XL, WILLHAMS BJ AND ROHR LR. (1994). Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet. Cytogenet., 75, 40-44.
11. BROWN JA, ALCARAZ A, TAKAHASHI S, PERSONS DL, LIEBER MM AND JENKINS RB. (1994). Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J. Urol., 152, 1157-1162.
12. COLLARD JG, VAN DE POLL M, SCHEFFER A, ROOS E, HOPMAN AH, GEURTS VAN KESSEL AH AND VAN DONGEN JJ. (1987). Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res., 47, 6666-6670.
13. CREMER T, LANDEGENT J, BRUCKNER A, SCHOLL H, SCHARDIN M, HAGER H, DEVILEE P, PEARSON P AND VAN DER PLOEG M. (1986). Detection of chromosome aberrations in human interphase nucleus by visualization of specific target DNAs. Hum. Genet., 74, 346-352.
14. DEVILLE P, THIRRY RF, KIEVITS T, KOLLURI R, HOPMAN AH, WILLARD HF, PEARSON PL AND CORNELISSE CJ. (1988). Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res., 48, 5825-5830.
15. HELSETH F, BROGGER A, DALEN A, FURE H, JOHANSEN SG, LIER ME, SKANDSEN T, UNSGAARD G AND VIK R. (1990). Polysomy of chromosome 7 is associated with amplification and overexpression of the EGF-receptor gene in a human carcinoma cell line derived from a brain metastasis. Acta Pathol. Microbiol. Immunol. Scand., 98, 996-1004.
16. HENKE RP AND AYHAN N. (1994a). Enhancement of hybridization efficiency in interphase cytogenetics on paraffin-embedded tissue sections by microwave treatment. Anal. Cellular Pathol., 6, 319-325.
17. HENKE RP, KRUGER E, AYHAN N, HUBNER D AND HAMMERER P. (1994b). Frequency and distribution of numerical chromosomal aberrations in prostatic cancer. Hum. Pathol., 25, 476-484.
18. HOPMAN AHN, RAMAEKERS FCS AND VOOIJS GP. (1990). Interphase cytogenetic of solid tumor. In In Situ Hybridization, Principles and Practice., Polak JM and McGee JO (eds) pp.165-186. Oxford University Press: Oxford.
19. KIBBELAAR RE, VAN KAMP H, DREEF EJ, WESSELS JW, BEVERSTOCK GC, RAAP AK, FIBBE WE, DEN OTTOLANDER GL AND KLUIN PM. (1991). Detection of trisomy 8 in hematological disorders by in situ hybridization. Cytogenet. Cell Genet., 56, 132-136.
20. KONIG JJ, TEUBEL W, VAN DONGEN JW, ROMIJN JC, HAGEMEIJER A AND SCHRONDER FH. (1994). Loss and gain of chromosomes 1, 18, and Y in prostate cancer. Prostate, 25, 281-291.
21. KORC M, MELTZER P AND TRENT J. (1986). Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc. Natl Acad. Sci. USA, 83, 5141-5144.
22. MACOSCA JA, TRYBUS TM, SAKR WA, WOLF MC, BENSON PD, POWELL IJ AND PONTES JE. (1994). Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res., 54, 3824-3830.
23. MATSUYAMA H, PAN Y, SKOOG L, TRIBUKAIT B, NAITO K, EKMAN P, LICHTER P AND BERGERHEIM US. (1994). Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene, 9, 3071-3076.
24. MICALE MA, MOHAMMED A, SAKR W, POWELL IJ AND WOLMAN SR. (1992). Cytogenetics of primary adenocarcinoma: clonality and chromosome instability. Cancer Genet. Cytogenet., 61, 165-173.
25. MICALE MA, SANFORD JS, POWELL IJ, SAKR WA AND WOLMAN SR. (1993). Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Cancer Genet. Cytogenet., 69, 7-12.
26. PFRSONS DL, HARTMANN LC, HERATH JF, BORELL TJ, CLIBY WA, KEENEY GL AND JENKINS RB. (1993). Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am. J. Pathol., 142, 733-741.
27. PERSONS DL, TAKAI K, GIBNEY DJ, KATZMANN JA, LIEBER MM AND JENKINS RB. (1994). Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma. Hum. Pathol., 25, 678-683.
28. PINKEL D, STRAUME T AND GRAY JW. (1986). Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl Acad. Sci. USA, 83, 3934-3938.
29. QIAN J, BOSTWICK DG, TAKAHASHI S, BORELL TJ, HERATH JF, LIEBER MM AND JENKINS RB. (1995a). Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res., 55, 5408-5414.
30. QIAN J, JENKINS RB AND BOSTWICK DG. (1995b). Chromosomal anomalies in atypical adenomutous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Urology, 46, 837-842.
31. TAKAHASHI S, QIAN J, BROWN JA, ALACARAZ A, BOSTWICK DG, LIEBER MM AND JENKINS RB (1994). Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res., 54, 3574-3579.
32. TRASK B AND PINKEL D. (1990). Fluorescence in situ hybridization with DNA probe. Methods Cell Biol., 33, 383-400.
33. TRENT JM, MEYSKEN FL, SALMAN SE, RYSCHON K, LEONG SP, DAVIS JR AND MCGEE DL. (1990). Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N. Engl. J. Med., 322, 1508-1511.
34. VISAKORPI T, HYYTINEN E, KALLIONIEMI A, ISOLA J AND KALLIONIEMI OP. (1994). Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am. J. Pathol., 145, 624-630.
35. WALDMAN FM, CARROLL PR, KERSCHMANN R, COHEN MB, FIELD FG AND MAYALL BH. (1991). Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51, 3807-3813.
36. WATANABE M, SHIRAISHI T, YATANI R, NOMURA AM AND STEMMERMANN GN. (1994a). International comparison on ras gene mutations in latent prostate carcinoma. Int. J. Cancer. 58, 174-178.
37. WATANABE M, USHIJIMA T, KAKIUCHI H, SHIRAISHI T, YATANI R, SHIMAZAKI J, KOTAKE T, SUGIMURA T AND NAGAO M. (1994b). p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries. Jpn J. Cancer Res., 85, 904-910.
38. WEAVER DJ, MICHALSKI K AND MILES K. (1988). Cytogenetic analysis in renal cell carcinoma: correlation with tumor aggressiveness. Cancer Res., 48, 2887-2889.
39. WOLMAN SR, MACOSKA JA, MICALE MA AND SAKR WA. (1992). An approach to definition of genetic alterations in prostate cancer. Diag. Molecular Pathol., 1, 192-199.
40. ZITZELSBERGER H, SZUCS S, WEIER HU, LEHMANN L, BRASELMANN H, ENDER S, SCHILLING A, BREUL J, HOFLER H AND BAUCHINGER. (1994). Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J. Pathol., 172, 325-335.